Streamex Corp. (STEX): R&D Expense
$31.0K
Year ended 2025-12-31
-82.5%
3-year compound annual growth
-72.0%
5-year compound annual growth
-32.2%
10-year compound annual growth
| Period ended | R&D Expense | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $31.0K | -96.3% | 2026-03-31, From 2025-01-01 |
| 2024-12-31 | $832.0K | -83.7% | 2026-03-31, From 2024-01-01 |
| 2023-12-31 | $5.09M | -12.5% | 2025-04-15, From 2023-01-01 |
| 2022-12-31 | $5.82M | +3.9% | 2024-04-16, From 2022-01-01 |
| 2021-12-31 | $5.60M | -69.1% | 2023-03-31, From 2021-01-01 |
| 2020-12-31 | $18.14M | +86.2% | 2022-03-31, From 2020-01-01 |
| 2019-12-31 | $9.74M | +122.9% | 2021-03-15, From 2019-01-01 |
| 2018-12-31 | $4.37M | -8.2% | 2020-03-13, From 2018-01-01 |
| 2017-12-31 | $4.76M | +79.2% | 2019-03-15, From 2017-01-01 |
| 2016-12-31 | $2.65M | +76.1% | 2018-02-27, From 2016-01-01 |
| 2015-12-31 | $1.51M | 0.0% | 2017-04-11, From 2015-01-01 |
| 2014-12-31 | $1.51M | +51.9% | 2017-04-11, From 2014-01-01 |
| 2013-12-31 | $992.2K | n/a | 2015-02-20, From 2013-01-01 |
R&D Expense at similar companies
| Company | Year ended | R&D Expense | Change YoY |
|---|---|---|---|
| Streamex Corp. (STEX) | 2025-12-31 | $31.0K | -96.3% |
| Ceribell, Inc. (CBLL) | 2025-12-31 | $19.14M | +41.2% |
| Axogen, Inc. (AXGN) | 2025-12-31 | $32.88M | +18.4% |
| Outset Medical, Inc. (OM) | 2025-12-31 | $21.23M | -44.7% |
| Vaso Corp (VASO) | 2025-12-31 | $728.0K | -14.5% |
| Biolife Solutions Inc (BLFS) | 2025-12-31 | $7.57M | +59.3% |
| Electromed, Inc. (ELMD) | 2026-06-30 | $1.31M | +31.9% |
| Hyperfine, Inc. (HYPR) | 2025-12-31 | $17.45M | -22.4% |
| Stereotaxis, Inc. (STXS) | 2025-12-31 | $9.38M | -3.9% |
Compare STEX, CBLL, AXGN, OM side by side · Screen every company in Electromedical & Electrotherapeutic Apparatus ↗